Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 50037338
TargetIntegrin alpha-V/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50409948(CHEMBL363098)
Affinity DataIC50: 0.400nMAssay Description:In vitro inhibitory activity against alpha v beta 3 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50150956(Imidazolyl O-guanidinium analogue | CHEMBL186712)
Affinity DataIC50: 3.40nMAssay Description:In vitro inhibitory activity against alpha v beta 3 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50150958(Imidazolyl O-guanidinium analogue | CHEMBL433785)
Affinity DataIC50: 6.10nMAssay Description:In vitro inhibitory activity against alpha v beta 3 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50409947(CHEMBL359601)
Affinity DataIC50: 7.20nMAssay Description:In vitro inhibitory activity against alpha v beta 3 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50409940(CHEMBL185580)
Affinity DataIC50: 9nMAssay Description:In vitro inhibitory activity against alpha v beta 3 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50409942(CHEMBL183253)
Affinity DataIC50: 10.5nMAssay Description:In vitro inhibitory activity against alpha v beta 3 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50150956(Imidazolyl O-guanidinium analogue | CHEMBL186712)
Affinity DataIC50: 13nMAssay Description:In vitro inhibitory activity against alpha IIb beta IIIa fibrinogen protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50409945(CHEMBL426254)
Affinity DataIC50: 20nMAssay Description:In vitro inhibitory activity against alpha v beta 3 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50150958(Imidazolyl O-guanidinium analogue | CHEMBL433785)
Affinity DataIC50: 25nMAssay Description:In vitro inhibitory activity against alpha IIb beta IIIa fibrinogen protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50150957(2-Benzenesulfonylamino-3-[(5-{2-[N-(4,5-dihydro-1H...)
Affinity DataIC50: 100nMAssay Description:In vitro inhibitory activity against alpha v beta 3 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50409941(CHEMBL185374)
Affinity DataIC50: 130nMAssay Description:In vitro inhibitory activity against alpha v beta 3 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50150957(2-Benzenesulfonylamino-3-[(5-{2-[N-(4,5-dihydro-1H...)
Affinity DataIC50: 170nMAssay Description:In vitro inhibitory activity against alpha IIb beta IIIa fibrinogen protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50409949(CHEMBL185557)
Affinity DataIC50: 310nMAssay Description:In vitro inhibitory activity against alpha v beta 3 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50150958(Imidazolyl O-guanidinium analogue | CHEMBL433785)
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro inhibitory activity against alpha 5 beta 1 fibronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50150956(Imidazolyl O-guanidinium analogue | CHEMBL186712)
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro inhibitory activity against alpha v beta 5 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50409946(CHEMBL184606)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro inhibitory activity against alpha v beta 3 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50150957(2-Benzenesulfonylamino-3-[(5-{2-[N-(4,5-dihydro-1H...)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro inhibitory activity against alpha 5 beta 1 fibronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50150957(2-Benzenesulfonylamino-3-[(5-{2-[N-(4,5-dihydro-1H...)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro inhibitory activity against alpha v beta 5 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50409944(CHEMBL184638)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro inhibitory activity against alpha v beta 3 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50409943(CHEMBL367809)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro inhibitory activity against alpha v beta 3 vitronectin protein interaction was measured by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2012
Entry Details Article
PubMed